OBJECTIVES: @entity150 shows low incidence and poor survival; thus, treatment algorithms based on randomized studies are unavailable. The aim of the present study is to review our case series. METHODS: Observational retrospective study of 10 @entity1 diagnosed with small cell @entity150 between 2006 and 2013. RESULTS: Mean age was 65.7 years; There was only one female in the cohort. In all cases @entity811 was the fist symptom. 4 cases presented high-grade papillary @entity189 with @entity4153 . Radical cystectomy was performed in 40% @entity1 , in combination with chemotherapy, radiotherapy or both. Median survival was 330 days (IC 95%: 40.757- 619.243) and only one @entity1 showed complete response. CONCLUSIONS: Even when small cell @entity150 is a low incidence @entity5 , its prognosis is worse than that of @entity189 . Although further randomized studies are needed to best define treatment, this study shows that survival at local stages is optimized by neoadjuvant chemotherapy, followed by radical resection, as the literature suggests.

XXXX : Our experience.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity4153 :: ('MESH:D018288', 'Disease') :: ['small cell carcinoma'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor'] @entity189 :: ('MESH:D002277', 'Disease') :: ['urothelial carcinoma'] @entity150 :: ('MESH:D001749', 'Disease') :: ['Small cell carcinoma of the bladder', 'carcinoma of the bladder'] @entity811 :: ('MESH:D006417', 'Disease') :: ['hematuria']
@entity150 :: (MESH:D001749,Disease) :: ['Small cell carcinoma of the bladder']
